Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,430 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $827.84 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $131.62 | 1 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $125.00 | 1 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $116.48 | 1 | $0 (2021) |
| Vifor Pharma, Inc. | $110.38 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $77.18 | 1 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $27.78 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $13.66 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $128.40 | 2 | Fresenius USA Marketing, Inc. ($128.40) |
| 2023 | $386.88 | 6 | Fresenius USA Marketing, Inc. ($248.22) |
| 2022 | $658.95 | 9 | Fresenius USA Marketing, Inc. ($311.99) |
| 2021 | $255.71 | 3 | Fresenius USA Marketing, Inc. ($139.23) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $107.43 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/19/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/20/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $23.17 | General |
| 11/16/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $96.46 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/16/2023 | Fresenius USA Marketing, Inc. | KORSUVA (Drug) | Food and Beverage | In-kind items and services | $105.45 | General |
| Category: KORSUVA a Kappa opioid receptor agonist for pruritus companied with chronic kidney disease CKD-aP | ||||||
| 03/23/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2023 | Fresenius USA Marketing, Inc. | KORSUVA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: KORSUVA a Kappa opioid receptor agonist for pruritus companied with chronic kidney disease CKD-aP | ||||||
| 02/22/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CRITICAL CARE | ||||||
| 12/06/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/01/2022 | Fresenius USA Marketing, Inc. | KORSUVA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Korsuva is a Kappa opioid receptor agonist for pruritus associated with kidney disease (CKD-aP) | ||||||
| 11/17/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/15/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/26/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $77.18 | General |
| Category: Cardio-renal | ||||||
| 08/11/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/23/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $131.62 | General |
| Category: Central Nervous System | ||||||
| 06/21/2022 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $110.38 | General |
| 10/18/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $119.59 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/13/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $116.48 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/06/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 496 | 3,063 | $466,156 | $182,955 |
| 2022 | 7 | 952 | 5,148 | $801,230 | $276,445 |
| 2021 | 6 | 1,097 | 4,680 | $739,130 | $243,406 |
| 2020 | 6 | 974 | 2,752 | $436,170 | $154,315 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 218 | 2,376 | $288,500 | $139,849 | 48.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 82 | 368 | $112,025 | $14,613 | 13.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 86 | 135 | $31,585 | $11,325 | 35.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 50 | 57 | $13,550 | $7,893 | 58.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 28 | 92 | $13,825 | $6,378 | 46.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 19 | 19 | $3,800 | $1,953 | 51.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 13 | 16 | $2,871 | $944.64 | 32.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 510 | 4,024 | $572,345 | $212,297 | 37.1% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Facility | 2022 | 206 | 605 | $121,000 | $32,741 | 27.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 85 | 244 | $39,720 | $16,415 | 41.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2022 | 56 | 165 | $49,500 | $6,973 | 14.1% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 30 | 33 | $7,480 | $4,278 | 57.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 27 | 27 | $6,250 | $2,042 | 32.7% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 38 | 50 | $4,935 | $1,699 | 34.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 501 | 3,449 | $512,480 | $172,493 | 33.7% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Facility | 2021 | 308 | 818 | $163,600 | $46,974 | 28.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 111 | 172 | $29,635 | $11,914 | 40.2% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 114 | 171 | $17,100 | $4,781 | 28.0% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 25 | 31 | $6,665 | $4,110 | 61.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 38 | 39 | $9,650 | $3,133 | 32.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 361 | 1,757 | $272,960 | $91,979 | 33.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 233 | 463 | $91,925 | $30,264 | 32.9% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 109 | 112 | $17,360 | $11,566 | 66.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 79 | 177 | $16,230 | $6,953 | 42.8% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Facility | 2020 | 90 | 110 | $22,000 | $6,908 | 31.4% |
About Rosamma Saji, NP
Rosamma Saji, NP is a Gerontology healthcare provider based in Garden City Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1861978561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rosamma Saji, NP has received a total of $1,430 in payments from pharmaceutical and medical device companies, with $128.40 received in 2024. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,430).
As a Medicare-enrolled provider, Saji has provided services to 3,519 Medicare beneficiaries, totaling 15,643 services with total Medicare billing of $857,121. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Other Specialties Adult Health
- Location Garden City Park, NY
- Active Since 07/16/2018
- Last Updated 07/16/2018
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1861978561
Products in Payments
- Velphoro (Drug) $551.09
- KORSUVA (Drug) $253.58
- AUSTEDO (Drug) $131.62
- TERLIVAZ (Drug) $125.00
- LUPKYNIS (Drug) $116.48
- Kerendia (Drug) $77.18
- Nuedexta (Drug) $27.78
- LOKELMA (Drug) $13.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.